Ozempic and GLP-1 Diet India
GLP-1 receptor agonists (Ozempic, Wegovy, Mounjaro, Rybelsus) are the biggest pharmaceutical breakthrough in weight management since metformin. In India, prescriptions have surged 300% since 2024, with an estimated 2-3 million Indians now using these medications. The results are dramatic: 15-25% body weight loss over 12 months. But there is a critical problem that most prescribing doctors in India are not addressing: up to 30-40% of the weight lost can be lean muscle mass, not just fat. This phenomenon — called "Ozempic body" or sarcopenic obesity reversal — leads to loose skin ("Ozempic face"), weakness, bone density loss, and metabolic slowdown that causes weight regain when the drug is stopped. The solution is not less medication. The solution is more protein and specific micronutrients. ## Why GLP-1 Drugs Cause Muscle Loss GLP-1 drugs work by: 1. Suppressing appetite (you eat 30-40% less) 2. Slowing gastric emptying (food stays in stomach longer) 3. Reducing glucagon secretion The problem: when you eat dramatically less, your body breaks down both fat AND muscle for energy. Without deliberate high-protein intake, the body preferentially loses muscle because it is metabolically expensive to maintain. A 2023 NEJM study found that without exercise and high protein, 39% of weight lost on semaglutide was lean mass. With resistance training + adequate protein, lean mass loss dropped to under 15%. ## The GLP-1 Protein Target Standard protein needs (0.8g/kg) are grossly insufficient during GLP-1-induced weight loss. ...
Delivery across India:
Gurgaon ·
Delhi ·
Noida ·
Faridabad ·
Ghaziabad ·
Chandigarh ·
Lucknow ·
Jaipur
Contact: +91-9811925380 · dietfull.care@gmail.com · Sector 36 Sohna, Gurugram, Haryana 122103